Communiqués SanBio Company Limited OTC Markets

Actions

SNBOY

US7995731004

Temps Différé OTC Markets Autres places de cotation 20:09:17 09/04/2024			Varia. 5j.	Varia. 1 janv.
2,81 ^USD	-48,72%		-.--%	-.--%

12:11	Les pertes attribuables de SanBio se réduisent au cours des trois mois d'exercice	MT
12/06	SanBio Company Limited annonce une mise à jour de l'état de la fabrication et de l'autorisation de mise sur le marché du programme Sb623 pour les lésions cérébrales traumatiques chroniques au Japon	CI

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

SanBio : Announcement on Granting Stock Options (Share Acquisition Rights)	16/08/22	PU
SanBio : Notice regarding appointment of new corporate officers	01/08/22	PU
SanBio : Update on Status of Manufacturing and Marketing Approval for SB623 Chronic Traumatic Brain Injury (TBI) Program in Japan	22/07/22	PU
SanBio : Keizo Nakada to Join SanBio as Corporate Officer and Head of Production	01/07/22	PU
SanBio : Recording of Non-operating Income (Foreign Exchange Gains), Deferred Income Taxes, and Short-Term Loans Payable	15/06/22	PU
SanBio : Consolidated Financial Results for the Three Months Ended April 30, 2022	14/06/22	PU
SanBio : Andrew Liu to Join SanBio as Chief Strategy Officer	01/06/22	PU
SanBio : SB623 Demonstrated Sustained Improvement in Motor Impairment up to 48 Weeks and Associated with Improvement	05/04/22	PU
SB623 Demonstrated Sustained Improvement in Motor Impairment up to 48 Weeks and Associated with Improvement in Function and Activities of Daily Living in Patients with Chronic Traumatic Brain Injury	05/04/22	BU
SanBio : ［Delayed］Recording of Non-Operating Expenses (Financing Expenses)	23/03/22	PU
SanBio : Partial Amendment to the Articles of Incorporation, Reduction in Amounts of Stated Capital and Capital Reserves and Appropriation of Capital Surplus	11/03/22	PU
SanBio : Announcement on Issuance Plans of Stock Options (Share Acquisition Rights)	11/03/22	PU
SanBio : Consolidated Financial Results for the Fiscal Year Ended January 31, 2022	11/03/22	PU
SanBio : Presentation for Financial Results for the Fiscal Year Ending Jan.31, 2022	11/03/22	PU
SanBio: Notice Regarding Completion of Approval Filing for Japan SB623 Chronic TBI Program	07/03/22	BU
SanBio : Notice regarding completion of approval filing for Japan SB623 chronic TBI program	07/03/22	PU
SanBio : Consolidated Financial Results for the Nine Months Ended October 31, 2021	16/12/21	PU
SanBio : Notice on the recording of other comprehensive income, non-operating income, and non-operating expenses	15/12/21	PU
SanBio : Notice on Conclusion of Committed Credit Line Agreement with Resona Bank Ltd.	15/12/21	PU
SanBio Joins the Newly Formed National TBI Registry Coalition (NTRC) as a Founding Member Organization	15/12/21	BU

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués SanBio Company Limited OTC Markets

Actions

SNBOY

US7995731004

Communiqués

Filtres